By G HossainPosted on June 26, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs The company is “especially excited” about an immune cell therapy manufacturing technology included in the deal, a Merck KGaA executive said. Merck KGaA inks $11B Bio-Techne buyout to expand into cell therapy production Post navigation IRS gives tax-exempt groups closer scrutinyModerna looks out to R&D ‘horizons’ as 2028 break-even goal looms